Stock Market & Financial Investment News

News Breaks December 7, 2012 18:10 EDT RHHBY Roche unit Genentech's Perjeta shows extended survival in breast cancer patients Genentech, a member of the Roche Group (RHHBY), announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta, Herceptin and docetaxel chemotherapy significantly extended the overall survival of people with previously untreated HER2-positive metastatic breast cancer, compared to Herceptin, chemotherapy and placebo. Results showed that the risk of death was reduced by 34% for people who received Perjeta, Herceptin and chemotherapy, compared to those who received Herceptin and chemotherapy. At the time of the analysis, median overall survival had not yet been reached in people receiving the Perjeta combination, as more than half of these people continued to survive. Median overall survival was 37.6 months for people who received Herceptin and chemotherapy. Based on these data, people receiving Herceptin and chemotherapy in CLEOPATRA have been offered the option to receive Perjeta. No new safety signals were observed in the study. News For RHHBY From The Last 14 Days Check below for free stories on RHHBY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 15, 2013 15:59 EDT RHHBY Roche exploring sale of blood glucose meters unit, Reuters says Subscribe for More Information 12:13 EDT RHHBY Roche management to meet with Jefferies Meeting to be held in London on May 17 hosted by Jefferies. 11:38 EDT RHHBY Roche says FDA approves Tarceva tablets for specific lung cancer situation Subscribe for More Information May 14, 2013 16:55 EDT RHHBY FDA approves Roche's cobas EGFR mutation test with Tarceva Subscribe for More Information May 13, 2013 08:55 EDT RHHBY Biosimiliar drug bill to be taken up in Senate, LA Times reports Subscribe for More Information 07:30 EDT RHHBY TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. May 10, 2013 15:59 EDT RHHBY Roche spokesman reiterates that Illumina is "off the table," Bloomberg reports Subscribe for More Information 11:48 EDT RHHBY Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information May 6, 2013 07:18 EDT RHHBY American Congress of Obstetrics and Gynecology to hold annual meeting Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.